Tuesday’s Top Biotech & Medical Stocks
From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotechnology NUVELO INC NEW +24.92% NEOSE TECH INC +20.67% CARDIOVASCULAR BIOTH +18.18% CV THERAPEUTICS I +17.93% REGENERON PHARMACE +14.88% Diagnostic Substances AVANT IMMUNOTHERAP +10.53% QUIDEL CP +7.43% AMER BIO MEDICA +7.02% SCOLR PHARMA…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
From BioHealth Investor
by H.S. Ayoub
BioHealth Investor.com
Biotechnology
NUVELO INC NEW [NUVO] +24.92%
NEOSE TECH INC [NTEC] +20.67%
CARDIOVASCULAR BIOTH [CVBT.OB] +18.18%
CV THERAPEUTICS I [CVTX] +17.93%
REGENERON PHARMACE [REGN] +14.88%
Diagnostic Substances
AVANT IMMUNOTHERAP [AVAN] +10.53%
QUIDEL CP [QDEL] +7.43%
AMER BIO MEDICA [ABMC] +7.02%
SCOLR PHARMA INC [DDD] +6.38%
ORCHID CELLMARK INC [ORCH] +6.30%
Drug Delivery
NOVADEL PHARMA INC [NVD] +6.06%
NEKTAR THERAPEUTIC [NKTR] +2.44%
COLUMBIA LABS INC [CBRX] +2.22%
BIOPROGRESS PLC [BPRG] +1.99%
IOMED INC [IOX] +1.79%
Drug Manufacturers
EXEGENICS INC [EXEG.OB] +30.16%
YM BIOSCIENCES INC [YMI] +6.80%
ADVANCIS PHARMA CP [AVNC] +3.69%
DUSA PHARM INC [DUSA] +3.68%
NEUROCHEM INC [NRMX] +3.43%
Drug Related Products
XELR8 HOLDINGS, INC [BZI] +5.33%
NATROL INC [NTOL] +3.38%
PERRIGO COMPANY [PRGO] +1.56%
ZILA INC [ZILA] +0.90%
DRAXIS HEALTH INC [DRAX] +0.64%
Generic Drugs
MYLAN LABS INC [MYL] +5.24%
PHARMACUTICAL CO [PRX] +1.69%
CATALYST PHARMACEUTI [CPRX] +0.49%
Medical Appliances & Equipment
ARRHYTHMIA RES TECH [HRT] +4.07%
CHAD THERAPEUTICS [CTU] +3.36%
ACCURAY INCORPORATED [ARAY] +2.79%
HANSEN MEDICAL, INC. [HNSN] +2.25%
REGENERATION TECH [RTIX] +2.20%
Medical Instruments & Supplies
MICROMED CARDIOVASCU [MMCV.OB] +5.00%
FOXHOLLOW TECH INC [FOXH] +4.84%
ANGIODYNAMICS INC [ANGO] +3.86%
QUANTRX BIOMEDICAL [QTXB.OB] +3.85%
IMPLANT SCIENCES CP [IMX] +3.47%
Medical Laboratories & Research
SPHERIX INC [SPEX] +7.42%
GENOMIC HEALTH, INC. [GHDX] +4.05%
MEDASORB TECHNOLOGS [MSBT.OB] +3.51%
NEOGENOMICS INC [NGNM.OB] +1.97%
ALLIANCE IMAGING INC [AIQ] +1.47%
http://www.biohealthinvestor.com/
Contact [email protected] for any questions or corrections.
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.